Introduction
============

Bacteria populate complex habitats in which extracellular conditions can change very rapidly. In order to survive in such an environment, bacterial cells have to be able to sense and respond to these variations before cell damage actually occurs. Therefore, bacteria need signal transducing systems that enable them to sense these extracellular changes and respond by differential gene expression.

A common mechanism to control gene expression at the level of transcription initiation is the use of σ factors, which constitute an essential subunit of the RNA polymerase (RNAP) holoenzyme and determine the promoter specificity. In addition to the primary σ factor, which is responsible for general expression of most genes in exponentially growing cells, most bacteria contain one or more alternative σ factors. These proteins are activated only under certain conditions and control expression of a specific set of target genes by recognizing alternative promoter sequences ([@b30]; [@b29]).

Most σ factors belong to the σ^70^ family based on their relation to the primary σ factor of *Escherichia coli*, σ^70^ ([@b24]; [@b50]). Based on sequence similarity, domain architecture and function, the proteins of the σ^70^ family can be divided into four groups. Group 1 comprises the essential primary σ factors, which contain four highly conserved domains (designated σ~1~ through σ~4~) ([@b24]). Group 2 σ factors are closely related to group 1 proteins, but are not essential for growth. The group 3 σ factors lack the σ~1~ domain and have functions in cellular processes such as sporulation, flagella biosynthesis, or heat shock response. The largest and most diverse group 4 contains the proteins of the ECF family, named after their function in response to extracellular stimuli ([@b42]; [@b28]; [@b12]).

In contrast to other σ^70^ proteins, the ECF σ factors only contain two of the four conserved domains, σ~2~ and σ~4~, which are sufficient for promoter recognition and interaction with RNAP. The bipartite promoter recognized by ECF σ factors typically contains a highly conserved "AAC" signature in the --35 region and a "CGT" motif in the --10 region ([@b28]). In general, ECF σ factors autoregulate their own expression and are cotranscribed with a gene encoding an anti-σ factor that regulates the activity of the σ factor. In the absence of a stimulus, the anti-σ factor binds the ECF σ factor and keeps it inactive. Upon receiving the appropriate signal, the anti-σ factor often gets inactivated, thereby releasing and activating the σ factor ([@b28]; [@b12]). The major principles of σ factor activation are based on either the regulated proteolysis of a membrane-anchored anti-σ factor as exemplified by RseA-σ^E^ of *E. coli* and RsiW-σ^W^ of *Bacillus subtilis* ([@b1]; [@b27]) or conformational changes of a soluble anti-σ factor, as has been described for RsrA-σ^R^ of *Streptomyces coelicolor* ([@b37]; [@b14]). For yet other examples, such as *S. coelicolor* σ^E^ or EcfG-homologs in α-proteobacteria, two-component systems play a crucial role in regulating the activity of the ECF σ factors ([@b32]; [@b23]).

A recent classification of the ECF σ factor protein family based on sequence similarity and genomic context conservation revealed a wide distribution and combinatorial complexity of ECF-dependent signal transduction. This study identified more than 40 phylogenetically distinct groups of ECF σ factors including major groups containing the *E. coli* σ^E^- and FecI-like proteins as well as cytoplasmic-sensing ECF σ factors. But in addition to these well-understood examples, a number of ECF groups were identified that have not yet been investigated experimentally ([@b59]).

Here, we describe the characterization of one such uncharacterized group, ECF41. This group is widely distributed with about 400 proteins from 10 different phyla. Based on their genomic organization, the genes encoding these ECF41 σ factors are not transcriptionally linked to genes encoding proteins related to known anti-σ factors. Instead, they are located next to genes encoding carboxymuconolactone decarboxylases, oxidoreductases, or epimerases. To extract general features of ECF41-dependent gene regulation, we experimentally investigated ECF41 σ factors from two different organisms, *B. licheniformis* (Firmicutes) and *Rhodobacter sphaeroides* (α-proteobacteria). In both organisms, the ECF41 σ factor appears to control expression of a single transcript that is preceded by a highly conserved ECF41-specific promoter motif. A unique feature of ECF41 proteins is the presence of a large C-terminal extension containing a number of conserved signature motifs. We provide evidence that this C-terminal extension is involved in regulation of σ factor activity and we propose that it functions as a fused anti-σ factor-like domain.

Materials and Methods
=====================

Bioinformatics analysis
-----------------------

A total of 510 ECF41 proteins were extracted in October 2010 from the MiST2 database ([@b61]) available at <http://mistdb.com>. False positives (unclassified ECF σ factors) and redundant proteins (proteins from more than one sequenced strain per species) were removed leaving 373 sequences for further analysis. Multiple sequence alignments were performed using ClustalW ([@b60]), and phylogenetic trees were generated from gapless multiple sequence alignments using the Neighbor-Joining method of the Phylip ([@b21]) program Protdist, both implemented in the BioEdit program package ([@b26]). Genomic context analysis was performed using the databases MicrobesOnline ([@b3]) at <http://www.microbesonline.org> and MiST2 ([@b61]) available at <http://mistdb.com/>. Protein domain architecture was analyzed using the SMART database ([@b54]; [@b41]) available at <http://smart.embl-heidelberg.de/>.

Two hundred fifty base pairs region upstream of the genes encoding the ECF41 σ factors and the corresponding carboxymuconolactone decarboxylases, oxidoreductases, or epimerases (COE) were analyzed for putative promoter motifs either manually or with the help of MEME ([@b6]), available at <http://meme.nbcr.net/>. Conservation of putative target promoters was illustrated using the WebLogo tool ([@b15]) at <http://weblogo.berkeley.edu>. The promoter sequence of group ECF41 σ factors was used to screen the genomes of *R. sphaeroides* 2.4.1 and *B. licheniformis* DSM13 for putative target genes with the help of the virtual footprint algorithm ([@b48]), implemented into the Prodoric database ([@b47]) at <http://www.prodoric.de/vfp/>. As input pattern, the generated position weight matrix or the promoter consensus as IUPAC code was used.

Bacterial strains and growth conditions
---------------------------------------

*Bacillus subtilis*, *B. licheniformis*, and *E. coli* were grown in LB medium at 37°C with aeration. *Rhodobacter sphaeroides* was grown aerobically in Sistrom\'s minimal medium ([@b56]) at 30°C. All strains used in this study are listed in [Table 1](#tbl1){ref-type="table"}. The antibiotics spectinomycin (100 μg/mL), chloramphenicol (5 μg/mL), and erythromycin (1 μg/mL) plus lincomycin (25 μg/mL) for macrolide-lincosamide-streptogram (MLS) resistance were used for selection of *B. subtilis* and *B. licheniformis* mutants. Plasmid containing *E. coli* strains were grown with ampicillin (100 μg/mL) or kanamycin (50 μg/mL). *Rhodobacter sphaeroides* mutants were selected using tetracycline (1 μg/mL), spectinomycin (25 μg/mL), or kanamycin (25 μg/mL).

###### 

Bacterial strains used in this study

  Strain                       Genotype or characteristic(s)                                                                         Source orreference
  ---------------------------- ----------------------------------------------------------------------------------------------------- --------------------
  *E. coli* strains                                                                                                                  
  S17--1                       C600::RP-4 2-(Tc::Mu)(Km::Tn*7*) *thi pro hsdR hsdM*^+^*recA*                                         [@b55]
  DH5α                         *recA1 endA1 gyrA96 thi hsdR17*(r~K~- m~K~+) *relA1 supE44 Φ*80Δ*lacZ*Δ*M15* Δ(*lacZYA-argF*)*U169*   [@b53]
  *B. subtilis* strains                                                                                                              
  W168                         Wild-type strain, *trpC2*                                                                             Laboratory stock
  1A774                        JH642 *rpoC*::(His~6~-tag) Spec^R^                                                                    BGSC (C. Moran)
  TMB1099                      1A774 pPH0401                                                                                         This study
  TMB1100                      1A774 pPH0403                                                                                         This study
  TMB1101                      1A774 pTW0412                                                                                         This study
  TMB695                       W168 pPH0401                                                                                          This study
  TMB746                       W168 pPH0403                                                                                          This study
  TMB666                       W168 pTW0412                                                                                          This study
  TMB428                       W168 *thrC*::pTW6302                                                                                  This study
  TMB455                       TMB428 *amyE*::pTW901                                                                                 This study
  TMB451                       W168 *amyE*::pTW901                                                                                   This study
  TMB456                       TMB428 *amyE*::pTW902                                                                                 This study
  TMB858                       W168 *amyE*::pPH901                                                                                   This study
  TMB574                       TMB451 *thrC*::pTW6304                                                                                This study
  TMB575                       TMB451 *thrC*::pTW6305                                                                                This study
  TMB577                       TMB451 *thrC*::pTW6307                                                                                This study
  TMB896                       TMB858 *thrC*::pTW6304                                                                                This study
  TMB897                       TMB858 *thrC*::pTW6305                                                                                This study
  TMB899                       TMB858 *thrC*::pTW6307                                                                                This study
  TMB623                       TMB428 pHCMC04                                                                                        This study
  TMB696                       TMB428 pPH0401                                                                                        This study
  TMB742                       TMB428 pPH0403                                                                                        This study
  TMB741                       TMB428 pPH0402                                                                                        This study
  TMB667                       TMB428 pTW0412                                                                                        This study
  *B. licheniformis* strains                                                                                                         
  DSM13                        Wild-type strain                                                                                      Laboratory stock
  MW3                          DSM13Δ*hsdR*1 Δ*hsdR*2                                                                                [@b62]
  TMBli003                     MW3 Δ*ydfG*                                                                                           This study
  TMBli006                     MW3 Δ*ecf*41~Bli~                                                                                     This study
  *R. sphaeroides* strains                                                                                                           
  2.4.1                        Wild-type strain                                                                                      Laboratory stock
  TMR003                       2.4.1 pTW0503                                                                                         This study
  TMR005                       YSD418 pTW0501                                                                                        This study
  TMR006                       YSD418 pTW0502                                                                                        This study
  TMR007                       YSD418 pTW0503                                                                                        This study
  YSD418                       2.4.1 P~RSP_0606~::pSUP202-*lacZ*                                                                     This study
  YSD354                       2.4.1 pIND4                                                                                           This study
  YSD239                       2.4.1 ΔRSP_0606-*ecf*41~Rsp~ Ω::Spec^R^                                                               This study
  YSD331                       YSD239 pIND4                                                                                          This study
  YSD333                       2.4.1 pYSD161                                                                                         This study
  YSD434                       YSD418 pIND4                                                                                          This study

DNA manipulations
-----------------

Standard cloning techniques were applied ([@b53]). All plasmids used in this study are listed in [Table 2](#tbl2){ref-type="table"}, oligonucleotides in [Table S2](#SD1){ref-type="supplementary-material"}. *Escherichia coli* strain S17--1 ([@b55]) was used for conjugational DNA transfer in *R. sphaeroides*. In brief, a 1:1 cell mixture of exponentially growing donor and recipient strains were harvested, washed, and resuspended in LB medium. The cell mixture was applied to a filter disc and incubated overnight on an LB plate at 30°C. The filter disc was transferred to Sistrom\'s minimal medium ([@b56]) and incubated for 3 h at 30°C on a shaker, before the cells were plated on agar plates with selection. Conjugants were obtained after three to four days of incubation at 30°C.

###### 

Vectors and plasmids used in this study

  Name                         Genotype or characteristic features[1](#tf2-1){ref-type="table-fn"}                       Primers for cloning   Source or reference
  ---------------------------- ----------------------------------------------------------------------------------------- --------------------- ---------------------
  Vectors                                                                                                                                      
  pDG1663                      *lacZ* fusion vector, integrates in *thrC*, MLS^R^                                                              [@b25]
  pHCMC04                      Xylose-inducible expression vector, Cm^R^                                                                       [@b49]
  pIND4                        IPTG-inducible expression vector, Kn^R^                                                                         [@b34]
  pSUP202                      Mobilizable vector, Ap^R^, Cm^R^, Tc^R^                                                                         [@b55]
  pSWEET                       Xylose-inducible expression vector, integrates in *amyE*, Cm^R^                                                 [@b8]
  pMAD                         Shuttle vector for construction of makerless deletion mutans, MLS^R^                                            [@b5]
  pHP45Ω                       Source of Ω::Spec^R^ cassette                                                                                   [@b52]
  pGEM-T                       Cloning vector                                                                                                  Promega Corp.
  Plasmids                                                                                                                                     
  pTW101                       pMAD *ecf*41~Bli~ up/do                                                                   779/780, 781/782      This study
  pTW102                       pMAD *ydfG* up/do                                                                         783/784, 785/786      This study
  pTW6302                      pDG1663 P*~ydfG~*~(-146--54)~-*lacZ*                                                      712/713               This study
  pTW6304                      pDG1663 P*~nhaX~*~(-355--40)~-*lacZ*                                                      1130/1131             This study
  pTW6305                      pDG1663 P*~ybpE~*~(-111--63)~-*lacZ*                                                      1136/1137             This study
  pTW6307                      pDG1663 P*~uvrX~*~(-173--54)~-*lacZ*                                                      1132/1133             This study
  pTW901                       pSWEET *ecf*41~Bli~                                                                       699/669               This study
  pTW902                       pSWEET *ecf*41~Bli~*-ydfG*                                                                699/705               This study
  pPH901                       pSWEET *ecf*41~Bliaa1--204~                                                               699/1576              This study
  pPH0401                      pHCMC04 *ecf*41~Bli~-FLAG                                                                 1416/1294             This study
  pPH0403                      pHCMC04 *ecf*41~Bli\ aa1--204~-FLAG                                                       1416/1469             This study
  pPH0402                      pHCMC04 *ecf*41~Bli\ aa1--192~-FLAG                                                       1416/1468             This study
  pTW0412                      pHCMC04 *ecf*41~Bli\ aa1--167~-FLAG                                                       1416/1411             This study
  pSUP202-*lacZ*               pSUP202 with promoter-less *lacZ* gene                                                    199/200               This study
  pSUP202-P~RSP_0606~-*lacZ*   P~RSP_0606~ fused to *lacZ* gene                                                          109/219               This study
  pYSD122                      pSUP202 with the Ω::Spec^R^ cassette and genomic regions flanking RSP_0606-*ecf*41~Rsp~   109/110/125/126       This study
  pYSD161                      pIND4 *ecf*41~Rsp~                                                                        185/186               This study
  pTW0501                      pIND4 *ecf*41~Rsp~                                                                        1881/1603             This study
  pTW0502                      pIND4 *ecf*41~Rsp\ aa1--169~                                                              1881/1604             This study
  pTW0503                      pIND4 *ecf*41~Rsp\ aa1--206~                                                              1881/1605             This study

Resistance cassettes: MLS^R^, macrolide-lincosamide-streptogram; Cm^R^, chloramphenicol; Kn^R^, kanamycin; Ap^R^, ampicillin; Tc^R^, tetracycline; Spec^R^, spectinomycin.

Construction of markerless *ecf*41~Bli~ and *ydfG* deletion mutants in *B. licheniformis*
-----------------------------------------------------------------------------------------

Markerless *B. licheniformis* Δ*ecf*41~Bli~ and Δ*ydfG* mutants were constructed using the vector pMAD ([@b5]). Seven hundred base pairs fragments up- and downstream of *ecf*41~Bli~ and *ydfG* were amplified by PCR using the oligonucleotides listed in [Table S2](#SD1){ref-type="supplementary-material"}, introducing extensions at the 3′ end of the up fragments that are complementary to the 5′ end of the down fragments. These regions were used to fuse the fragments in a second joining PCR. The resulting products were then cloned into pMAD using BamHI and EcoRI generating pTW101 and pTW102. The plasmids were introduced into *B. licheniformis* MW3 as described ([@b62]). Generation of markerless deletion mutants basically followed the established procedure ([@b5]). In brief, transformants were incubated at 30°C with MLS selection on LB agar plates supplemented with X-Gal. Blue colonies were picked and incubated for 6--8 h at 42°C in LB medium with MLS selection, resulting in the integration of the plasmid into the chromosome. Again, blue colonies were picked from LB X-Gal plates and incubated for 6 h at 30°C in LB medium without selection. Subsequently, the liquid culture was shifted to 42°C for 3 h, and the cells were then plated on LB X-Gal plates, this time without selective pressure. White colonies that had lost the plasmid were picked and deletion of *ecf*41~Bli~ or *ydfG* was checked by PCR.

Construction of an RSP_0606-*ecf*41~Rsp~ deletion mutant in *R. sphaeroides*
----------------------------------------------------------------------------

RSP_0606-*ecf*41~Rsp~ with 1.3 kb flanking regions on both sides was amplified from chromosomal DNA of *R. sphaeroides* using oligonucleotides 109 and 110 ([Table S2](#SD1){ref-type="supplementary-material"}) and ligated into the vector pGEM-T (Promega, Madison). To replace RSP_0606-*ecf*41~Rsp~ with a resistance cassette, the regions flanking the genes and the plasmid were amplified using internal oligonucleotides (125, 126) and ligated to the Ω fragment derived from pHP45Ω ([@b52]), conferring spectinomycin resistance. The resulting construct was amplified using oligonucleotides 109 and 110, cloned into the suicide vector pSUP202 (which contains a tetracycline resistance marker) digested with ScaI to make pYSD122. The plasmid pYSD122 was than conjugated into *R. sphaeroides* 2.4.1. Double recombinants corresponding to the deletion mutants were selected for spectinomycin resistance and sensitivity to tetracycline. Plasmid constructs were verified by sequencing, and the deletion in the *R. sphaeroides* genome was verified by PCR.

Measurement of promoter activity by β-galactosidase assays
----------------------------------------------------------

Because of the lack of genetic tools for *B. licheniformis*, we developed a heterologous expression system in *B. subtilis*, an organism lacking an ECF41 σ factor. A DNA fragment from *B. licheniformis* containing the intergenic region between *ydfG* and *ecf*41~Bli~ was fused to a promoter-less *lacZ* gene using the vector pDG1663 and integrated into the *thrC* locus of *B. subtilis*. In addition, we fused a FLAG-tag to the N-terminus of Ecf41~Bli~ and its truncated versions and expressed the protein from the xylose-inducible promoter of the shuttle vector pHCMC04, allowing determination of P*~ydfG~* activity by β-galactosidase assays in response to Ecf41~Bli~ expression.The resulting *B. subtilis* strains were inoculated from fresh overnight cultures and grown in LB medium at 37°C with aeration until they reached an OD~600~ of ∼0.4. The cultures were split and 0.5% xylose was added to one sample to induce expression of Ecf41~Bli~ from the inducible promoter. After incubation for 1 h at 37°C, 2 mL of each sample were harvested and the cell pellets frozen at --20°C. The pellets were resuspended in 1 mL working buffer and assayed for β-galactosidase activity with normalization to cell density ([@b46]).

A DNA fragment containing the upstream region of RSP_0606 was amplified and cloned into the suicide vector pSUP202 carrying a promoter-less *lacZ* gene. The resulting plasmid was conjugated into *R. sphaeroides* and integrated into the chromosome by single crossing over, thereby bringing the expression of β-galactosidase under control of P~RSP_0606~. Full-length and truncated *ecf*41~Rsp~ was amplified and cloned into the overexpression vector pIND4, thereby bringing its expression under control of an IPTG-inducible promoter. The resulting *R. sphaeroides* strains were grown aerobically in Sistrom\'s minimal medium ([@b56]) to an OD~600~ of ∼0.3. The cultures were split and expression of Ecf41~Rsp~ was induced in one sample by adding 100 μM IPTG. After 3 h, the cells were harvested and β-galactosidase activity was measured as described ([@b46]).

Preparation of total RNA
------------------------

*Bacillus licheniformis* MW3 (wt) and TMBli003 (Δ*ecf*41~Bli~) were grown aerobically in LB medium at 37°C. Every 2 h, 30 mL samples were taken and mixed with cold killing buffer (20 mM Tris-HCl, pH 7.0, 0.5 mM MgCl~2~, 20 mM NaN~3~), harvested by centrifugation, and frozen in liquid nitrogen, before the pellets were stored at --80°C. The cells were resuspended in 200 μL killing buffer, immediately transferred to a precooled Teflon vessel and disrupted with a Micro-Dismembrator U (Sartorius) for 3 min at 2000 rpm. The resulting cell powder was resuspended in 3 mL prewarmed lysis solution (4 M guanidine-thiocyanate, 25 mM sodium acetate, pH 5.2, 0.5% *N*-lauroyl sarcosinate) and total RNA was extracted twice with acid phenol (phenol/chloroform/isoamylalcohol 25/24/1, pH 4.5--5) and once with chloroform (chloroform/isoamylalcohol 24/1) followed by isopropanol precipitation. Contaminating DNA was removed using the Baseline-ZERO DNAse (Epicentre Biotechnologies, Madison) according to the manufacturer\'s protocol. RNA was quantified with a NanoDrop 1000 Spectrophoto-meter (Thermo Scientific, Schwerte) and used for 5′RACE and Northern Blot analysis.

*Rhodobacter sphaeroides* YSD354 (pIND4) and YSD333 (pYSD161) were grown aerobically in Sistrom\'s minimal medium ([@b56]) containing 25 μg/mL kanamycin at 30°C. At OD~600~ of ∼0.3, expression of Ecf41~Rsp~ was induced by adding 100 μM IPTG. After 3 h, 44 mL of culture was mixed with 6 mL stop solution (5% acid phenol in ethanol) and harvested by centrifugation. The pellets were frozen in an ethanol/dry ice bath and stored at --80°C. Cells were resuspended in 2 mL lysis solution (2% SDS, 16 mM EDTA) and incubated at 65°C for 5 min. RNA was extracted three times with acid phenol prewarmed to 65°C followed by chloroform extraction and isopropanol precipitation. To remove contaminating DNA, the RNA was incubated with two units RQ1 DNase (Promega, Madison) in the presence of 80 units RNasin Plus RNase Inhibitor (Promega, Madison) for 30 min at 37°C. The RNA was finally purified with the RNeasy Mini Kit (Qiagen, Hilden) and used for DNA Microarray analysis and 5′RACE.

Probe preparation and Northern Blot analysis
--------------------------------------------

An ∼500 bp internal fragment of *ydfG* was amplified by PCR with oligonucleotides listed in [Table S2](#SD1){ref-type="supplementary-material"}. A digoxigenin (DIG)-UTP-labeled RNA probe was synthesized by in vitro transcription using the DIG RNA Labeling Mix (Roche, Mannheim) and T7 RNA polymerase (Roche, Mannheim) according to the manufacturer\'s protocol.

For Northern Blot analysis, 10 μg of total RNA was separated under denaturing conditions on a 1% formaldehyde agarose gel and transferred to a positively charged nylon membrane (Roche, Mannheim) in a downward transfer using 20× SSC (3 M NaCl, 0.3 M sodium citrate, pH 7.0) as transfer buffer. The RNA was crosslinked by exposing the membrane to UV light. The blot was prehybridized at 68°C for 1 h with hybridization solution (5× SSC, 50% formamide, 2% Blocking Reagent (Roche, Mannheim), 0.1% *N*-lauroyl sarcosinate, and 0.02% SDS). Hybridization was carried out overnight at 68°C in the same solution with 1 μg DIG-labeled RNA probe. The membrane was washed twice for 5 min at room temperature (2× SSC, 0.1% SDS) and three times for 15 min at 68°C (0.1× SSC, 0.1% SDS). The signal was detected with an antidigoxigenin antibody conjugated to alkaline phosphatase (Roche, Mannheim) and CDP-*Star* (Roche, Mannheim) according to the manufacturer\'s instructions. The signals were visualized using a LumiImager (Peqlab, Erlangen).

DNA microarray analysis
-----------------------

RNA samples from three independent cultivations were used for cDNA synthesis and DNA microarray hybridization. A total of 10 μg of total RNA was mixed with 3 μg random hexamers and denatured at 70°C for 10 min before the temperature was decreased in six cycles (1 min each) by 10°C/cycle to 10°C to optimize annealing of the hexamers. cDNA was synthesized using SuperScript II Reverse Transcriptase (Invitrogen, Karlsruhe) according to the manufacturer\'s instruction. Temperature was increased from 20°C to 42°C in 22 cycles of 3 min with 1°C increment followed by incubation at 42°C for 1 h and inactivation at 70°C for 10 min. Remaining RNA was removed by alkaline hydrolysis and cDNA was purified using the PCR Purification Kit (Qiagen, Hilden). A total of 3.2 μg cDNA was fragmented with 0.25 units RQ1 DNase (Promega, Madison) for 10 min at 37°C followed by inactivation for 10 min at 98°C. cDNA was labeled using the BioArray Terminal Labeling Kit with Biotin-ddUTP for DNA Probe Array Assays (Enzo, Farmingdale) according to the manufacturer\'s protocol. Labeled cDNA samples (3 μg/array) were hybridized to Affymetrix (Santa Clara, CA) custom arrays ([@b51]) according to the manufacturer\'s directions. Processing, normalization, and statistical analysis of the array data were performed in the R Statistical Software environment (<http://www.r-project.org/>). Data were normalized using the *affyPLM* package with default settings ([@b10]). Differentially expressed genes were detected using the *limma* package with a false discovery rate set at 0.05 ([@b57]).

Determination of transcriptional start sites by 5′-RACE
-------------------------------------------------------

The 5′ ends of *ydfG* and RSP_0606 mRNAs were identified by rapid amplification of cDNA ends (RACE). A total of 15 μg of total RNA was incubated with 25 units tobacco acid pyrophosphatase (TAP, Epicentre Biotechnologies, Madison) in the delivered buffer at 37°C for 60 min in the presence of 40 units Super RNaseIn RNAse inhibitor (Ambion, Austin). As a control, 15 μg RNA was incubated under the same conditions, but without TAP. The reactions were phenol/chloroform extracted and ethanol precipitated. After dissolving the pellets in water, the RNA was mixed with 500 pmol RACE adapter (5′-GAUAUGCGCGAAUUCCUGUAGAACGAACACUAGAAGAAA-3′) and denatured at 95°C for 5 min. Ligation of the adapter was carried out at 17°C overnight with 100 units T4 RNA ligase (Epicentre Biotechnologies, Madison) in the presence of 80 units Super RNaseIn RNAse inhibitor (Ambion, Austin). Again, the reactions were phenol/chloroform extracted, ethanol precipitated, and the pellets were resuspended in water. One microgram RNA was used for reverse transcription with gene-specific primers (GSP1, [Table S2](#SD1){ref-type="supplementary-material"}) and the iScript Select cDNA Synthesis Kit (Bio-Rad, München) according to the manufacturer\'s protocol. The cDNA was then amplified with nested primers and a primer complementary to the RACE adapter sequence (GSP2 and 679, [Table S2](#SD1){ref-type="supplementary-material"}) and the transcription start sites were identified by sequencing.

Western Blot analysis
---------------------

*Bacillus subtilis* strains containing overexpression plasmids were grown in LB medium at 37°C to an OD~600~ of ∼0.4. Expression of Ecf41~Bli~-FLAG and its variants was induced by adding 0.5% xylose. After 1 h, 15 mL of each culture was harvested. The pellets were resuspended in ZAP buffer (10 mM Tris, pH 7.4, 200 mM NaCl), cells were lysed by sonication, and cell debris was removed by centrifugation. A total of 20 μg of the cleared lysate was separated by SDS-PAGE and transferred to a Polyvinylidene difluoride (PVDF) membrane using a Mini Trans-Blot Electrophoretic Transfer Cell (Bio-Rad, München) according to the manufacturer\'s instructions. The membrane was then incubated overnight at 4°C with blotto (2.5% skim milk in TBS \[50 mM Tris, pH 7.6, 150 mM NaCl\]) to prevent nonspecific binding. Then, the membrane was incubated with the primary antibody (anti-FLAG \[Sigma, München\] diluted 1:2000 in blotto) at room temperature for 1 h followed by four 10 min washing steps with blotto. Then the blot was incubated for 1 h with the secondary antibody (anti-rabbit IgG HRP conjugate \[Promega\] diluted 1:2000 in blotto). After four washing steps with blotto, the membrane was washed with TBS before the signals were detected with a LumiImager (Peqlab, Erlangen) using AceGlow (Peqlab, Erlangen) as chemiluminescence substrate.

RNAP pull-down assays
---------------------

Different versions of Ecf41~Bli~-FLAG under control of a xylose-inducible promoter were introduced into *B. subtilis* 1A774, which contains a His~6~-tag fused to the β′ subunit of the RNAP, to form strains TMB1099 (wt Ecf41~Bli~), TMB1100 (Ecf41~Bli~ 204), and TMB1101 (Ecf41~Bli~ 167). As controls, the same constructs were transformed into *B. subtilis* W168 resulting in TMB695, TMB746, and TMB666. The RNA pull-down assays were performed as described previously ([@b45]). In brief, 100 mL LB medium supplemented with 5 μg/mL chloramphenicol was inoculated from fresh overnight cultures and grown till OD~600~ ∼0.4. Cultures were induced with 0.5% xylose for 1 h and cells were harvested by centrifugation. The pellets were resuspended in phosphate buffer (50 mM phosphate buffer, pH 7.6, 100 mM NaCl, 0.1 mM PMSF, 5 mM imidazole) and cells were lysed by sonication. The cleared lysate was loaded on a column containing 0.5 mL Ni-NTA metal affinity beads. The beads were washed with each 10 column volumes of the above-mentioned phosphate buffer containing 5, 10, and 20 mM imidazole. Elution was carried out using 0.5 mL phosphate buffer with increasing imidazole concentration (50, 100, 250, and 500 mM). Samples of the cleared lysate, washing steps, and elution fractions were run in duplicates on 10% and 12% SDS-PAGE gels and checked for presence of RNAP (coomassie staining) and Ecf41~Bli~-FLAG (Western Blot using anti-FLAG anti-bodies). For quantitative analysis, 5 μg of lysate as well as 5 and 10 μg of the 100 mM imidazole elution fractions were used and analyzed as mentioned above.

Results
=======

In silico analysis of group ECF41 σ factors
-------------------------------------------

### Phylogenetic distribution

The initial analysis of group ECF41 ([@b59]) was based on a dataset generated in 2008 containing 115 ECF41 protein sequences from five different phyla. To account for the huge increase in bacterial genomes sequenced within the last three years, we reanalyzed group ECF41 based on 373 ECF41 σ factors extracted from the Microbial Signal Transduction Database (MiST2) ([@b61]) ([Table S1](#SD1){ref-type="supplementary-material"}).

Group ECF41 shows a wide taxonomic distribution and proteins of this group can be found in 10 different phyla, but predominantly in the Actinobacteria and Proteobacteria ([Table 3](#tbl3){ref-type="table"}). In addition, ECF41 σ factors can also be found in the phyla Firmicutes, Chloroflexi, Acidobacteria, Bacteriodetes, Cyanobacteria, Spirochaetes, Verrucomicrobia, and Gemmatimonadetes.

###### 

Phylogenetic distribution of ECF41 σ factors

  Phyla              ECF41 proteins per phylum   Percentage of ECF41 proteins   Species with ECF41 protein   Percentage of sequenced species   Sequenced genomes/species[1](#tf3-1){ref-type="table-fn"}
  ------------------ --------------------------- ------------------------------ ---------------------------- --------------------------------- -----------------------------------------------------------
  Actinobacteria     252                         68                             60                           51                                181/118
  Proteobacteria     84                          23                             66                           15                                705/414
  Firmicutes         15                          4.0                            10                           2.5                               404/182
  Chloroflexi        11                          2.9                            3                            60                                15/5
  Acidobacteria      4                           1.1                            4                            67                                6/6
  Bacteriodetes      2                           0.5                            2                            4.4                               53/45
  Cyanobacteria      2                           0.5                            2                            6.3                               44/32
  Spirochaetes       1                           0.3                            1                            5.6                               23/18
  Verrucomicrobia    1                           0.3                            1                            25                                4/4
  Gemmatimonadetes   1                           0.3                            1                            100                               1/1

Numbers of sequenced genomes and species of each phylum were extracted from the MiST2 database ([@b61]) in October 2010.

The 373 proteins of group ECF41 derive from 150 different species. Therefore, these organisms often encode more than one copy of the ECF41 gene in the genome ([Tables 3](#tbl3){ref-type="table"} and [S1](#SD1){ref-type="supplementary-material"}). Especially within the Actinobacteria, multiple copies are very common. Only 14 of the 60 ECF41-containing actinobacterial species harbor just one copy of this σ factor, while the genomes of the remaining 46 contain several copies. Especially the genus *Streptomyces* contains large numbers of ECF41 σ factors with at least four copies per genome, which may reflect the complex lifestyle of these bacteria ([@b22]). The ECF41 copy number correlates well with the genome size and the overall abundance of signal trans-ducing systems. For example, the genome of *S. coelicolor* encodes as many as 45 ECF σ factors ([@b7]), 13 of which belong to group ECF41. A high abundance of ECF41 genes can also be found in the phylum Chloroflexi (11 ECF41 σ factors/3 genomes), whereas most of the Proteobacteria (84 ECF41 σ factors/66 genomes) and Firmicutes (15 ECF41 σ factors/10 genomes) harbor only one to two ECF41 σ factors per genome.

We constructed an unrooted phylogenetic tree based on a gapless multiple sequence alignment of all 373 ECF41 σ factors using the neighbor-joining method implemented in the Phylip program Protdist ([@b21]) provided by the BioEdit Sequence Alignment Editor ([@b26]). In general, the terminal nodes representing sequences of ECF41 σ factors cluster according to the phylum ([Fig. 1](#fig01){ref-type="fig"}). The two phyla containing the highest number of sequences (Actinobacteria and Proteobacteria) are divided into five and three different branches, respectively. One cluster within one actinobacterial branch is rather diverse and includes ECF σ factors from Proteobacteria, Chloroflexi, Firmicutes, and Acidobacteria. The remaining ECF41 σ factors from Firmicutes as well as Chloroflexi form single branches. The ECF41 proteins from Bacteriodetes and Cyanobacteria also cluster together, whereas the proteins from Acidobacteria, Spirochaetes, Verrucomicrobia, and Gemmatimonadetes cluster within or between actinobacterial and proteobacterial branches ([Fig. 1](#fig01){ref-type="fig"}).

![Phylogenetic tree of ECF41 σ factors. The phylogenetic tree is based on a gapless multiple sequence alignment of 373 ECF41 protein sequences constructed using ClustalW ([@b60]). The resulting phylogenetic tree was calculated using the neighbor-joining method of the Phylip ([@b21]) program Protdist implemented in the BioEdit Sequence Alignment Editor ([@b26]). Assignment to bacterial phyla is indicated by a color code. Ecf41~Rsp~ of *Rhodobacter sphaeroides*, Ecf41~Bli~ of *Bacillus licheniformis*, and σ^J^ of *Mycobacterium tuberculosis* are highlighted.](mbo30001-0194-f1){#fig01}

### Genomic context conservation

In contrast to most ECF σ factors studied to date ([@b12]), no gene encoding an obvious anti-σ factor can be found in direct vicinity of the genes encoding the ECF41 σ factors. Instead, they are genomically associated with genes encoding carboxymuconolactone decarboxylases, oxido-reductases, or epimerases (collectively referred to as "COE" from here on) ([Fig. 2](#fig02){ref-type="fig"}). While this genomic context is highly conserved, the order and orientation of the associated genes is diverse. In almost 50% of the cases, both genes are orientated in the same direction and could potentially be transcribed as an operon. In less than 20%, the genes are orientated divergently. The remaining ∼30% of ECF41 σ factors do not cluster with genes encoding COEs ([Table 4](#tbl4){ref-type="table"}). Such "orphans" are especially abundant in actinobacterial species ([Fig. 2](#fig02){ref-type="fig"}), which often contain multiple copies of ECF41 genes in the genome ([Table S1](#SD1){ref-type="supplementary-material"}). Here, at least one copy of the ECF41 genes shows the conserved genomic context.

###### 

Genomic context and promoter occurrence

  Genomic context[1](#tf4-1){ref-type="table-fn"}   Number      P~ECF~[2](#tf4-2){ref-type="table-fn"}   P~COE~[2](#tf4-2){ref-type="table-fn"}
  ------------------------------------------------- ----------- ---------------------------------------- ----------------------------------------
  \>ECF\>                                           126 (34%)   38                                       n.a.
  \>COE\> \>ECF\>                                   107 (29%)   --                                       97
  \>ECF\> \>COE\>                                   53 (14%)    14                                       24
  \>ECF\> \<COE\<                                   9 (2%)      3                                        4
  \<ECF\< \>COE\>                                   55 (15%)    36                                       41
  Ungrouped                                         23 (6%)     n.a.                                     n.a.

The arrows indicate the organization of the genes. ECF, gene encoding an ECF41 σ factor; COE, gene encoding a carboxymuconolactone decarboxylase, oxidoreductase, or epimerase; ungrouped, genomic context differs from the above-mentioned groups and contains genes encoding hypothetical proteins of unknown function.

"-", no promoter occurs upstream of the gene; n.a., the corresponding gene is not present or was omitted from analysis in case of ungrouped genomic context.

![Genomic context conservation of ECF41 σ factors. ECF σ factors are shown by black, carboxymuconolactone decarboxylases by gray, oxidoreductases by striped and epimerases by dotted arrows. Genes encoding hypothetical proteins, that either contain the conserved ECF41-dependent promoter motif ([Fig. 4](#fig04){ref-type="fig"}) or are located between the ECF41 σ factor and the COE, are displayed in white. The genomic context is represented according to the phylum with the number of species in parentheses. The number in front of each context indicates how often this combination of genes occurs within the designated phylum.](mbo30001-0194-f2){#fig02}

![Targets of ECF41-dependent signal transduction. (A) Genomic context organization and target promoter sequence of the ECF41 σ factors from *B. licheniformis* and *R. sphaeroides*. Genes encoding the ECF41 σ factor (black) and the carboxymuconolactone decarboxylase (gray) as well as the promoter sequences are shown. Flanking genes not belonging to the ECF41 loci are shown in white. The --35 and --10 region, the transcriptional start site +1, and the ATG start codon are highlighted in bold. The RACE adapter sequence is indicated by lower case letters. (B) Northern Blot analysis of Ecf41~Bli~-dependent *ydfG* expression in *B. licheniformis*. *Bacillus licheniformis* MW3 (wt) and TMBli003 (Δ*ecf*41~Bli~) were grown aerobically in LB medium. At the time points indicated by arrows, samples of both strains were harvested and total RNA was prepared. A total of 10 μg total RNA was separated on a 1% formaldehyde gel and transferred to a nylon membrane followed by hybridization and detection with a DIG-labeled *ydfG*-specific probe. Ribosomal RNA is shown to ensure equal amounts of RNA in each lane. (C) Weblogo of ECF41-dependent target promoters. The weblogo was generated using the WebLogo tool ([@b15]) available at <http://weblogo.berkeley.edu>. The weblogo graphically represents a position weight matrix and illustrates the degree of sequence conservation for each nucleotide. The matrix is based on 285 putative promoter sequences identified upstream of genes encoding ECF41 σ factors and COEs. (D) ECF41-dependent target promoter activation. *Bacillus subtilis* strains TMB696 (Ecf41~Bli~) and TMB623 (pHCMC04) were grown in LB medium to OD~600~ ∼0.4 and split into two samples. In one sample, expression of Ecf41~Bli~ was induced by addition of 0.5% xylose and cells were harvested after 1 h. *Rhodobacter sphaeroides* strains TMR005 (Ecf41~Rsp~) and YSD434 (pIND4) were grown in Sistrom\'s minimal medium to OD~600~ ∼0.3 and split into two samples. In one sample, expression of Ecf41~Rsp~ was induced by 100 μM IPTG. After 3 h, the cells were harvested. P*~ydfG~* and P~RSP_0606~ activities were measured by β-galactosidase assays with normalization to cell density.](mbo30001-0194-f4){#fig04}

*Carboxymuconolactone decarboxylases*. Commonly, proteins of the carboxymuconolactone decarboxylase family (PF02627) can be divided into two main groups: the γ-carboxymuconolactone decarboxylases and the AhpD-like alkylhydroperoxidases ([@b35]). The γ-carboxymuconolactone decarboxylases are involved in the degradation of aromatic compounds. They catalyze the decarboxylation of γ-carboxymuconolactone to β-ketoadipate enol-lactone in the protocatechuate branch of the β-ketoadipate pathway ([@b20]). The best investigated example of the second group is the alkylhydroperoxidase AhpD of *Mycobacterium tuberculosis*. This protein contains a CxxC motif critical for catalytic activity and is part of the antioxidant defense system of this organism ([@b31]; [@b38]). In the archaeon *Methanosarcina acetivorans*, it was shown that the product of gene MA3736 encodes an uncharacterized carboxymuconolactone decarboxylase homolog with disulfide reductase activity dependent on a CxxC motif ([@b40]). It was suggested to play a role in the oxidative stress response of this organism. All carboxymuconolactone decarboxylases genomically linked to ECF41 σ factors contain a conserved CxxC motif, suggesting a role of this group in the defense against oxidative stress.

*Oxidoreductases*. The reactions catalyzed by oxido-reductases can be very diverse, but are always characterized by the transfer of electrons from one molecule to another, often using NAD(P)H or FAD as cofactors. Since oxidoreductases can use a variety of different molecules as electron donor or acceptor, it is difficult to assign a specific function to these enzymes. In case of genes next to ECF41 σ factors, they were classified as oxidoreductase if their product carried at least one of the following Pfam domains: Oxidored_FMN, Flavodoxin_2, Pyr_redox/\_2, FAD_binding_2/3/4, Amino_oxidase, Pyridox_oxidase, or FMN_red.

*Epimerases*. The third group contained either an NmrA (PF05368) or an Epimerase (PF01370) domain. NmrA is a negative transcriptional regulator of AreA and involved in nitrogen metabolite repression in different fungi. The crystal structure of NmrA revealed a Rossmann-fold and similarity to members of the short-chain dehydrogenase/reductase family ([@b58]), which generally deploy nucleotide--sugar substrates for chemical conversions. The Rossmann-fold is typical for two-domain redox enzymes that use NAD^+^ as cofactor. The UDP-galactose 4-epimerase is the best understood example of this family and catalyzes the conversion of UDP-galactose to UDP-glucose ([@b2]).

*Miscellaneous*. In some cases, genes encoding other than the above-mentioned proteins can also be linked to ECF41 σ factors. These neighboring genes were included in [Figure 2](#fig02){ref-type="fig"} if they (1) carry the typical promoter sequence (see below and [Fig. 4](#fig04){ref-type="fig"}), or (2) are located between the ECF41- and the COE-encoding genes. Most of these other genes encode hypothetical proteins of unknown function. Four of these hypothetical proteins ([Table S1](#SD1){ref-type="supplementary-material"}) contain the conserved β-barrel domain of the cupin superfamily, which members often function as dioxygenases in bacteria ([@b19]). The C-terminal domain of the cytoplasmic anti-σ factor ChrR from *R. sphaeroides* σ^E^ also adopts such a cupin fold ([@b13]). In all four cases, the genes encoding these cupin fold proteins are in the same orientation than the ECF σ factor and presumably form an operon.

### ECF41 proteins contain a large C-terminal extension

Group 4 alternative σ factors contain the smallest proteins of the σ^70^ family, in which only regions σ~2~ and σ~4~ are present and sufficient for promoter recognition and RNAP interaction. An alignment of classical ECF σ factors from different organisms and proteins of group ECF41 revealed a large C-terminal extension of about 100 amino acids only present in ECF41 σ factors ([Fig. 3](#fig03){ref-type="fig"}). Based on an alignment of all ECF41 proteins ([Fig. S1](#SD1){ref-type="supplementary-material"}), we identified three conserved motifs within this extension ([Fig. 3](#fig03){ref-type="fig"}). Another characteristic feature of the ECF41 proteins is a highly conserved WLPEP motif in the linker region between σ~2~ and σ~4~, which usually does not show much sequence conservation in other ECF σ factors.

![Characteristic features of group ECF41 proteins and comparison with classical ECF σ factors. The multiple sequence alignment of selected ECF σ factors was constructed using ClustalW ([@b60]). Identical amino acids at the same position are shaded in black, similar amino acids in gray. The σ~2~ and σ~4~ domains and the C-terminal extension are marked. Conserved motives of ECF41 proteins are defined by the complete multiple sequence alignment of group ECF41 ([Fig. S1](#SD1){ref-type="supplementary-material"}) and are highlighted. Abbreviations: Bce, *Bacillus cereus*; Bli, *B. licheniformis*; Bsu, *B. subtilis*; Eco, *Escherichia coli*; Nfa, *Nocardia farcinica*; Rsp, *Rhodobacter sphaeroides*; Reu, *Ralstonia eutropha*.](mbo30001-0194-f3){#fig03}

By analogy to other group 4 σ factors, we expect activity of the ECF41 proteins to be regulated in response to some unknown signal. Based on the observations regarding the genomic context and domain architecture of ECF41 σ factors, we propose three hypotheses to explain their regulation: (1) the COE genes could be targets of ECF41-dependent regulation, (2) the COEs could be part of the signal transducing mechanism and function as an anti-σ factor, or (3) the C-terminal extension could be involved in controlling σ factor activity.

To address these hypotheses directly and generalize our findings, we experimentally investigated ECF41 σ factors from two different organisms: BLi04371 of *B. licheniformis* and RSP_0607 of *R. sphaeroides*. We named the genes encoding the ECF41 σ factors to *ecf*41~Bli~ and *ecf*41~Rsp~ and used these terms for the following analysis. The genomic neighborhood including the genes encoding the carboxymuconolactone decarboxylases YdfG and RSP_0606 is shown in [Figure 4A](#fig04){ref-type="fig"}.

Targets of ECF41 σ factors
--------------------------

### COE-encoding genes represent targets of ECF41-dependent signal transduction

We first investigated if the COE-encoding genes next to the ECF41 σ factors are targets of the ECF41-dependent signal transduction. Therefore, we monitored expression of *ydfG* at different growth phases in a *B. licheniformis* wild-type and an isogenic Δ*ecf*41~Bli~ deletion strain. Both strains show no difference in growth behavior ([Fig. 4B](#fig04){ref-type="fig"}), indicating that Ecf41~Bli~ is not required under standard laboratory conditions. At designated time points, samples of both strains were taken, total RNA was prepared, and Northern Blot analysis was performed using a *ydfG*-specific probe. At the transition from the exponential to the stationary growth phase, an ∼0.5 kb transcript appears in the wild-type strain in agreement with a monocistronic expression of *ydfG* ([Fig. 4B](#fig04){ref-type="fig"}). No *ydfG* transcript is visible in the Δ*ecf*41~Bli~ deletion mutant, demonstrating that detectable expression of *ydfG* is completely Ecf41~Bli~-dependent under the conditions tested.

We also examined the transcriptome upon overexpression of Ecf41~Rsp~ in *R. sphaeroides* by DNA microarrays to test if a similar result can be obtained in another organism and to possibly identify additional target genes of ECF41 σ factors. Strains containing either an Ecf41~Rsp~ overexpression plasmid (YSD333) or the empty vector (YSD354) were grown aerobically to OD~600~ ∼0.3 and expression of the ECF41 σ factor was induced by adding IPTG. After 3 h of incubation, the cells were harvested, total RNA was prepared, and microarray analysis performed (see materials and methods for details). The mRNA level for *ecf*41~Rsp~ was ∼80-fold increased in cells overexpressing this protein. The only other more than twofold-induced gene was RSP_0606 (∼threefold), which encodes the associated carboxymuconolactone decarboxylase (data not shown). With this approach, we cannot discriminate between the expression level of the native and the ectopic copy of *ecf*41~Rsp~. Nevertheless, we propose that *ecf*41~Rsp~ and RSP_0606 form a bicistronic operon due to an overlap of the structural genes. Taken together, these results indicate that Ecf41~Rsp~ seems to control expression of only a single transcript that contains the *ecf*41~Rsp~ and RSP_0606 genes.

### Analysis of ECF41-dependent target promoters in *B. licheniformis* and *R. sphaeroides*

Since ECF σ factors recognize alternative promoter sequences, we investigated if the identified ECF41 target genes *ydfG* and RSP_0606 are preceded by such a unique sequence motif. We therefore mapped the transcriptional start site by 5′RACE in RNA samples from cells overexpressing the ECF41 σ factor (*R. sphaeroides*) or samples taken throughout the growth cycle (*B. licheniformis*) ([Fig. 4B](#fig04){ref-type="fig"}). In both organisms, we identified a "G" residue as the transcriptional start site followed by a 22/23 bp untranslated region containing a suitable ribosome-binding site ([Fig. 4A](#fig04){ref-type="fig"}). Upstream of this start point, we identified a bipartite sequence motif with similarity to typical ECF-dependent promoter elements ([@b28]; [@b59]): a --35 region identical in both organisms (TGTCACA) and a --10 region (TGTT or CGTC).

Next, we tested if this predicted target promoter responds to the corresponding ECF41 σ factor. Because of the lack of genetic tools for *B. licheniformis*, we heterologously expressed Ecf41~Bli~-FLAG from a xylose-inducible promoter in *B. subtilis*, an organism lacking an ECF41 σ factor, and measured the activity of the target promoter P*~ydfG~* trans-criptionally fused to *lacZ* by β-galactosidase assays ([Fig. 4D](#fig04){ref-type="fig"}). Without xylose, the resulting reporter strain TMB696 shows only low P*~ydfG~* activity, presumably due to weak basal expression of Ecf41~Bli~ from P*~xylA~* in complex LB medium. Addition of 0.5% xylose increased promoter activity ∼70-fold, indicating that Ecf41~Bli~ activates P*~ydfG~* upon its overexpression. Almost no β-galactosidase activity was detectable in the control strain TMB623, harboring only the empty expression vector, demonstrating that P*~ydfG~* from *B. licheniformis* is not recognized and activated by any σ factor of *B. subtilis* under the laboratory conditions used in these experiments.

To test for promoter recognition in *R. sphaeroides*, we expressed Ecf41~Rsp~ from an IPTG-inducible promoter and measured the activity of the target promoter P~RSP_0606~ by β-galactosidase assays. Without inducer present, strain TMR005 shows P~RSP_0606~ activity of about 25 Miller Units, which can be increased twofold by addition of IPTG ([Fig. 4D](#fig04){ref-type="fig"}). The high P~RSP_0606~ activity of TMR005 in the absence of IPTG is presumably due to background transcription from the leaky promoter of the expression plasmid. In comparison, the control strain YSD434, which carries the empty vector, shows only marginal promoter activity. These results from two independent organisms demonstrate that the promoter identified by 5′RACE ([Fig. 4A](#fig04){ref-type="fig"}) specifically responds to the overexpression of ECF41 σ factors.

### Prediction of a general ECF41-dependent target promoter motif

After we identified an ECF41-dependent promoter in two organisms, we expected that this motif should also be present in the ECF41 loci of other organisms. To verify this, we extracted 250-bp regions upstream of the COE- as well as the ECF41-encoding genes and searched for overrepresented sequence motifs with similarity to the identified promoter, either manually or by using the MEME algorithm ([@b6]). We identified the two motifs described above separated by a 16 ± 1 bp spacer within most of these regions and constructed a weblogo based on 285 sequences ([Fig. 4C](#fig04){ref-type="fig"}). The --10 region with the consensus "CGTC" is comparable to many typical ECF promoters, whereas the --35 consensus "TGTCACA" is specific for group ECF41. This bipartite promoter motif can be found upstream of both the COE- and ECF41-encoding genes, often preceding a potential operon consisting of these two genes ([Tables 4](#tbl4){ref-type="table"} and [S1](#SD1){ref-type="supplementary-material"}). In about one-third of all ECF41 σ factors, the COE-encoding gene is located upstream of and in the same orientation than the ECF gene. Here, the COE gene usually carries the promoter motif while the ECF41 σ factor lacks it. In case of this predominant locus organization, both genes could form an operon transcribed from the COE promoter. If the ECF σ factor is located upstream of the COE gene, less than 30% of the ECF- and almost 50% of the COE-encoding genes harbor the promoter, in case of 20% both genes are preceded by the motif. About 17% of the ECF41 σ factors show opposite orientation relative to the COE gene, either \>ECF\>\<COE\< or \<ECF\< \>COE\>. In the latter case, often both genes are preceded by the motif, whereas for the first combination usually only either the ECF- or COE-encoding gene shows the promoter. More than 30% of all ECF41 σ factors do not show the genomic context conservation. Of these "orphan" genes, only 30% are preceded by the ECF41-specific promoter.

Next, we used the derived position weight matrix graphically represented in [Figure 4C](#fig04){ref-type="fig"} to perform genome-wide searches for additional ECF41 target promoters in *R. sphaeroides* and *B. licheniformis*, using the algorithm virtual footprint ([@b48]) implemented in the Prodoric database ([@b47]). In both organisms, only a few potential ECF41 target promoters could be identified ([Table 5](#tbl5){ref-type="table"}), but none exactly matched the ECF41 consensus. Construction of transcriptional *lacZ*-fusions to three of these promoters from *B. licheniformis* (P*~nhaX~*, P*~uvrX~*, and P*~ypbE~*) and subsequent determination of β-galactosidase activity did not reveal any Ecf41~Bli~-dependent activation. Even expression of a highly active truncated version of Ecf41~Bli~ (see below) did not result in any promoter activation (data not shown). In addition, we performed a genome-wide analysis on the presence and conservation of the ECF41-dependent promoter motif upstream of orthologous genes in a wide range of ECF41-harboring organisms. While this in silico analysis has been successfully used to identify candidate promoters and core regulons for other regulators including ECF σ factors ([@b17], [@b18]), it failed to reveal any potential conserved regulon members, with the exception of genes encoding the COEs or ECF41 σ factors (data not shown). Taken together, our collective data strongly suggest that the proteins of group ECF41 generally control expression of only a single target gene or operon, which includes the COE and the ECF41 σ factor, if cotranscribed. The COE-encoding genes therefore represent the only known and detectable targets of ECF41-dependent gene expression.

###### 

Putative ECF41 target promoters in *B. licheniformis* and *R. sphaeroides*

  Gene[1](#tf5-1){ref-type="table-fn"}   Promoter sequence^2^                         5′UTR^3^   Putative function, homology
  -------------------------------------- -------------------------------------------- ---------- -------------------------------------------------
  *B. licheniformis*                                                                             
  BLi01248                               [TGTCACA]{.ul}AAAACATAAATAATAGA[TGTC]{.ul}   142        Hypothetical, putative membrane protein
  Bli03073                               [TGTCACC]{.ul}CCTTCCTT-TTTCGAGC[CGTC]{.ul}   109        Hypothetical, putative membrane protein
  *hprP*                                 [TGTCACG]{.ul}CTTGCTTTTATTTTTCT[CGTC]{.ul}   163        Putative phosphatase
  *mtrB*                                 [TGTCACT]{.ul}TCAGCTGT-AAGGGGAA[CGTT]{.ul}   76         Transcription attenuation protein
  ***nhaX***                             [TGTCACG]{.ul}TTTAGGTG--CTTTTGT[TGTT]{.ul}   199        Stress response protein
  *pucR*                                 [TGTCACA]{.ul}AATCCGCT--CATTTTT[TGTT]{.ul}   39         Purine catabolism regulatory protein
  *sat*                                  [TGTCACA]{.ul}AGCGTTCTGCTGGCATC[TGTC]{.ul}   97         Sulfate adenylyltransferase, dissimilatory-type
  *spoIISB*                              [TGTCACA]{.ul}GAATTTGA-TTATCTCC[TGTT]{.ul}   60         Stage II sporulation protein SB
  ***uvrX***                             [TGTCACC]{.ul}TTCTTTCC-AAAGAAGG[TGTT]{.ul}   120        DNA-damage repair protein
  *ybxF*                                 [TGTCACT]{.ul}AAAAATTG-TCATCATA[TGTT]{.ul}   68         Firmicutes ribosomal L7Ae family protein
  ***ydfG***                             [TGTCACA]{.ul}AACTCCGT-TTCTCTCT[TGTT]{.ul}   31         Putative carboxymuconolactone decarboxylase
  *yfmE*                                 [TGTCACG]{.ul}GCAATGAT-TGGGACGC[CGTT]{.ul}   42         Heme ABC type transporter HtsABC, permease
  *ykpA*                                 [TGTCACA]{.ul}AAGAAAGTGGAAATAAG[CGTT]{.ul}   108        ABC transporter, ATP-binding protein
  ***ypbE***                             [TGTCACG]{.ul}GCACATTTTTTGATCGA[TGTT]{.ul}   48         Unknown, LysM domain, cell wall degradation
  *yvdI*                                 [TGTCACA]{.ul}CTGCTCATTTCTTTCAT[TGTC]{.ul}   63         Maltose/maltodextrin ABC transporter
  *R. sphaeroides*                                                                               
  *gcvH*                                 [TGTCACG]{.ul}TCCGGCG-GCTTCGGCC[CCTC]{.ul}   151        Glycine cleavage system H protein,
  *repA*                                 [TGTCACC]{.ul}GTTTCG--CCCCAAGAA[CGTG]{.ul}   152        RepA partitioning protein/ATPase, ParA type
  *rplL*                                 [TGTCACC]{.ul}CACC--ATGTTGGACCC[CATC]{.ul}   20         Ribosomal protein
  **RSP--0606**                          [TGTCACA]{.ul}ACCGC-CTTCCCTCGCC[CGTC]{.ul}   32         Putative carboxymuconolactone decarboxylase

Genes highlighted in bold were tested for activation by the corresponding ECF41 σ factor.^2^Underlining indicates --35 (left) and --10 (right) regions, the spacing was adjusted indicated by dashes.^3^5′UTR, length of 5′-untranslated region (in nucleotides) between the postulated transcriptional start site and the AUG start codon.

### Phenotypes linked to ECF41-dependent gene expression

The analysis of the function of ECF41-dependent target genes could provide some hints for the physiological role of this novel group of ECF σ factors. The only detectable target gene of the ECF41 σ factor in both *B. licheniformis* and *R. sphaeroides* encodes a carboxymuconolactone decarboxylase, which is usually involved in the degradation of aromatic compounds ([@b20]; [@b43]). But besides this function, proteins annotated as carboxymuconolactone decarboxylases can also exhibit a role in the oxidative stress response ([@b31]; [@b40]). Additionally, a strain of *M. tuberculosis* lacking the ECF41 σ factor σ^J^ is slightly more sensitive to H~2~O~2~ ([@b33]). Based on these observations, we investigated a potential link between ECF41 σ factors and oxidative stress response. We performed serial dilution spot tests to compare the viability of an *R. sphaeroides* wild-type (YSD354) and RSP_0606-*ecf*41~Rsp~ deletion mutant (YSD331) or Ecf41~Rsp1--206~ overexpression strain (TMR003, expressing a highly active version of Ecf41~Rsp~, see below) as well as *B. licheniformis* wild-type (MW3) and Δ*ecf*41~Bli~ (TMBli006) or Δ*ydfG* (TMBli003) deletion strains, respectively. No significant differences were observed in the presence of the oxidative stress generating compounds H~2~O~2~, cumene hydroperoxide, *t*-butyl hydro-peroxide, or paraquat (data not shown).

We subsequently performed a phenotype microarray (PM) analysis. This high-throughput approach allows testing hundreds of different conditions in parallel in order to identify phenotypes associated with genetic alterations ([@b9]). Our PM analysis included 960 assays for carbon, nitrogen, phosphorus, and sulfur utilization, nutrient stimulation, pH and osmotic stress, as well as chemical sensitivity tests covering 240 different substances (see <http://www.biolog.com/PM_Maps.html> for details). We compared phenotypic differences between the *R. sphaeroides* wild-type (2.4.1) and RSP_0606-*ecf*41~Rsp~ deletion strain (YSD239) as well as a strain expressing the highly active variant of Ecf41~Rsp~ (TMR003; see below). Overall, only very few phenotypes can be linked to the expression or deletion of the ECF41 σ factor. Besides resistance to spectinomycin due to the resistance cassette, strain YSD239 showed only a positive phenotype against the sulfonamide anti-biotic sulfadiazine. As expected, strain TMR003 displayed relative resistance to aminoglycoside antibiotics (kanamycin, neomycin, geneticin, paromomycin) due to the resistance cassette of the overexpression plasmid. Surprisingly, gained phenotypes were observed for the carbon sources adonitol, [d]{.smallcaps}-mannitol, [d]{.smallcaps}-sorbitol, and glucose, suggesting a metabolic function of the ECF41 σ factors in utilization of additional carbon sources. But none of these additional phenotypes not due to the presence of a resistance cassette could be verified by serial dilution spot tests (data not shown). Taken together, the mutant and overexpression strains do not show any reproducible growth differences compared to the wild type under all the conditions tested. Therefore, we were not able to identify an ECF41-related phenotype.

Signal transduction of ECF41 σ factors
--------------------------------------

The activity of ECF σ factors is normally regulated by a cognate anti-σ factor. The genes encoding these two proteins are usually located next to each other on the chromosome and cotranscribed ([@b28]; [@b12]). As mentioned above, no obvious anti-σ factor is encoded in direct vicinity to the genes encoding the ECF41 σ factors. The results of our in silico analysis ([Figs. 2](#fig02){ref-type="fig"} and [3](#fig03){ref-type="fig"}) suggest that either the corresponding COEs or the C-terminal extension of the ECF41 proteins could be involved in the regulation of σ factor activity. We first tested if YdfG has any influence on the target promoter activation by Ecf41~Bli~. Therefore, we expressed Ecf41~Bli~ separately (TMB455) and simultaneously with YdfG (TMB456) in *B. subtilis* and measured the activity of P*~ydfG~* fused to *lacZ* by β-galactosidase assays, but did not observe any significant differences (data not shown). Therefore, we do not have any indication that the corresponding COEs are involved in ECF41-dependent signal transduction and focused our attention on the C-terminal extension. To study a possible function of this extension, we investigated the effect of C-terminal truncations of Ecf41~Bli~ on promoter activation and RNAP interaction.

### Sequential deletion analysis of the C-terminal extension

We constructed three C-terminally truncated alleles of *ecf*41~Bli~-FLAG and tested their ability to activate the target promoter P*~ydfG~*. The different mutant proteins were named according to their length ([Fig. 5A](#fig05){ref-type="fig"}). Truncation of the C-terminal part of the extension (204) resulted in a very active ECF σ factor leading to an ∼20-fold increase in P*~ydfG~* activity relative to the full-length protein. Surprisingly, further truncation (192) of Ecf41~Bli~ resulted in clearly decreased target promoter activation. Furthermore, expression of variant 167, which lacks the whole extension, completely lost the ability to activate the target promoter ([Fig. 5B](#fig05){ref-type="fig"}). This was unexpected, since regions σ~2~ and σ~4~ are usually sufficient for promoter recognition and activation by other ECF σ factors. This indicates that at least N-terminal parts of the extension are required for ECF41-dependent promoter activation, although partly truncations lead to a highly active protein. Expression of all of these Ecf41~Bli~-FLAG variants was verified by Western Blot ([Fig. 5B](#fig05){ref-type="fig"}).

![Effect of C-terminal truncations of ECF41 σ factors on target promoter activation. (A) Schematic representation of C-terminally truncated Ecf41~Bli~ proteins of *B. licheniformis*. The name of each variant is given at the beginning of each line and correlates with the length of the protein. The domains σ~2~ and σ~4~ as well as the C-terminal extension are displayed as gray boxes. The amino acid sequence of the highly conserved motives is shown. (B) β-galactosidase activities of *B. subtilis* strains overexpressing truncated Ecf41~Bli~-FLAG proteins. Strains TMB696 (wt), TMB742 (204), TMB741 (192), and TMB667 (167) were grown in LB medium to OD~600~ ∼0.4 and split into two samples. In one sample, protein expression was induced by addition of 0.5% xylose. The cells were harvested after 1 h and β-galactosidase activity was measured. Expression of the Ecf41~Bli~ variants was verified by Western Blot using a FLAG-tag-specific antibody and is shown below. (C) Schematic representation of C-terminally truncated Ecf41~Rsp~ proteins of *R. sphaeroides*. Details are shown as described for [Figure 4](#fig04){ref-type="fig"}. (D) β-galactosidase activities of *R. sphaeroides* strains overexpressing truncated Ecf41~Rsp~ proteins. Strains TMR005 (wt), TMR006 (169), and TMR007 (206) were grown in Sistrom\'s minimal medium to OD~600~ ∼0.4 and split into two samples. In one sample, expression of Ecf41~Rsp~ variants was induced by 100 μM IPTG. After 3 h, the cells were harvested and β-galactosidase assays were performed.](mbo30001-0194-f5){#fig05}

To test if similar results can be observed for Ecf41~Rsp~, we tested the effects of C-terminal truncations on σ factor function ([Fig. 5C and D](#fig05){ref-type="fig"}). Expression of the C-terminal truncated Ecf41~Rsp~ (206) led to ∼120-fold higher P~RSP_0606~ activity than the full-length protein, whereas deletion of the whole extension (169) resulted in a total loss of promoter activation. Our collective data therefore strongly suggest that the C-terminal extension of group ECF41 proteins might represent a fused regulatory domain that is involved in controlling σ factor activity.

### Interaction of Ecf41~Bli~ with RNA polymerase

Bacterial σ factors form a complex with the RNAP core enzyme and recruit the resulting holoenzyme to the corresponding target promoters ([@b11]). To demonstrate that Ecf41~Bli~ interacts with RNAP, we performed in vivo RNAP pull-down assays. Ecf41~Bli~-FLAG was expressed from a xylose-inducible promoter in a *B. subtilis* strain carrying a His~6~-tagged β′-subunit of RNAP. The His~6~-tag was used for rapid purification of RNAP holoenzyme ([@b4]). The success of the purification was verified by the presence of bands on a Coomassie-stained SDS-PAGE gel corresponding to the ββ′ and α subunits ([Fig. 6A](#fig06){ref-type="fig"}). Western Blot analysis with a FLAG-tag-specific antibody shows that Ecf41~Bli~-FLAG copurifies with RNAP ([Fig. 6B](#fig06){ref-type="fig"}). The same protein is not detectable in the elution samples of cells lacking the His~6~-tag (data not shown) indicating that enrichment of Ecf41~Bli~-FLAG from *B. licheniformis* is due to interaction with RNAP.

![Interaction of Ecf41~Bli~ with RNA polymerase. (A) SDS-PAGE of Ni affinity-purified proteins from strains TMB1099 (wt), TMB1100 (204), and TMB1101 (167) carrying a His~6~-tag fused to the β′ subunit of the RNAP. The different truncated versions of Ecf41~Bli~-FLAG were overexpressed and the RNAP complex was purified (see Materials and Methods for details). A total of 5 μg of the cleared lysate and 5 and 10 μg of the 100 mM imidazole elution fraction were loaded. (B) Detection of copurified Ecf41~Bli~-FLAG and its variants by Western Blot analysis of a gel identical to the one in (A) using a FLAG-tag-specific antibody.](mbo30001-0194-f6){#fig06}

Next, we analyzed if the observed effect of Ecf41~Bli~ truncations ([Fig. 5A and B](#fig05){ref-type="fig"}) on target promoter activation can be explained by their ability to interact with RNAP core enzyme. We repeated the RNAP pull-down assay quantitatively with the highly active (204), the inactive (167), and the wild-type version of Ecf41~Bli~-FLAG. All three proteins are expressed at comparable levels in soluble form as demonstrated by Western Blot analysis of the cleared lysate before purification, but show considerable different binding behavior to RNAP ([Fig. 6B](#fig06){ref-type="fig"}). Hardly any binding can be observed for the shortest Ecf41~Bli~ protein (167), which is consistent with its inability to activate the target promoter ([Fig. 5B](#fig05){ref-type="fig"}). In contrast, the protein with only partly truncated extension (204) co-purifies with RNAP to a much lesser extent than the full-length protein although promoter activation is significantly higher.

Taken together, C-terminal truncations of Ecf41~Bli~ significantly alter the binding behavior to RNAP, but this affinity does not completely reflect the observed σ factor activity of the corresponding allele. While loss of promoter activation for the complete deletion of the C-terminal extension can be---at least partially---explained by the significantly reduced ability of the shortest version of Ecf41~Bli~ (167) to interact with RNAP, additional factors must account for the strongly increased promoter activation of the partly truncated version (204), despite its weaker interaction with RNAP compared to the wild-type protein.

Taken together, our data demonstrate that the ECF41 σ factors seem to have a completely new way of signal trans-duction presumably not involving a second protein functioning as an anti-σ factor. Instead, the C-terminal extension, which is not present in other ECF σ factors, affects both the target promoter activation and binding to RNAP ([Figs. 5](#fig05){ref-type="fig"} and [6](#fig06){ref-type="fig"}). The mechanism of this mode of regulation remains to be investigated in subsequent studies.

Discussion
==========

A recent classification identified a large number of novel groups of ECF σ factors with unique features compared to "classical" ECF σ factors ([@b59]), including group ECF41. This group shows a wide phylogenetic distribution with about 400 proteins from 10 different phyla ([Tables](#tbl3){ref-type="table"} and S1; [Fig. 1](#fig01){ref-type="fig"}). The genomic context of group ECF41 is highly conserved and distinct from other ECF groups. An obvious anti-σ factor is missing. Instead, a gene encoding a carboxymuconolactone decarboxylase, an oxidoreductase, or an epimerase (COE) is located directly up- or downstream of the ECF41 σ factor ([Fig. 2](#fig02){ref-type="fig"}). We did not observe any function of the COE proteins in signal transduction, but identified the neighboring genes encoding these proteins as the sole targets of ECF41 σ factors, both by in silico and comprehensive gene expression analyses. We identified a unique promoter signature (TGTCACA-n~16~-CGTC) upstream of these COE genes that is recognized by the corresponding ECF41 σ factor ([Fig. 4](#fig04){ref-type="fig"}).

The most important finding of our study concerns the regulatory role of the C-terminal extension of group ECF41, which is not present in any other group of ECF σ factors ([@b59]). Based on our data, ECF41-dependent signal transduction does not seem to involve a second protein that functions as an anti-σ factor. Instead, our data clearly demonstrate the importance of the C-terminal extension for both target promoter activation and affinity to RNAP ([Figs. 5](#fig05){ref-type="fig"} and [6](#fig06){ref-type="fig"}). Moreover, our sequential deletion analysis indicates that the extension plays both a positive and negative role in ECF41-dependent gene regulation. A short N-terminal part of the extension directly following the region σ~4~ is absolutely required for σ factor activity, in contrast to other ECF σ factors described so far. But most of the C-terminal part of the extension clearly plays a negative regulatory role: even partial deletions result in a strongly increased activity of the target promoters in both organisms studied ([Fig. 5](#fig05){ref-type="fig"}), suggesting that this part of the extension functions as a fused inhibitory domain. To our knowledge, this is the first report of a regulatory domain being fused to the ECF σ factor. Based on our results, we propose that the group of ECF41 σ factors represents a novel mechanism of ECF-dependent signal transduction.

While our data clearly establish a regulatory role of the C-terminal extension for the activity of the ECF41 σ factor, the exact molecular mechanism will be the subject of further investigations. One possibility would be that the C-terminal extension functions as a sensory domain. In the absence of a suitable trigger, it could keep the σ factor domains inactive through intra- or intermolecular interactions. These interactions could prevent the binding of the ECF41 σ factor to RNAP or promoter DNA. The presence of an input signal could then result in a conformational change that releases the σ factor domains from the inhibitory grip of the extension, thereby initiating transcription of the COE genes. Such a mechanism involving intramolecular interactions has for example been described for the primary σ factor of *E. coli*, σ^70^. While this σ factor does not need to be activated, binding of free σ^70^ to DNA is inhibited by region 1.1, presumably by interaction with the σ~4~ DNA-binding domain ([@b16]). A similar inhibitory role of N-terminal regions has also been shown for alternative σ factors such as *E. coli* σ^32^ and *B. subtilis* σ^K^ ([@b16]; [@b36]). Another attractive but completely hypothetical possibility is that ECF41 proteins exist as inactive dimers in the cell with the extension being the dimerization interface. Activation would involve conformational changes and dissociation, resulting in a monomeric form that is able to interact with RNAP and promoter DNA. If a similar mechanism involving intra- or intermolecular interactions also applies to the C-terminal region of ECF41 σ factors needs to be investigated.

Alternatively, though maybe less likely, a stimulus sensed by the C-terminal regulatory domain could also result in a conformational change that exposes a protease recognition site. After regulated cleavage, the truncated and thereby activated σ factor would then mediate transcription initiation. Alternative σ factors such as σ^K^ and σ^E^, which are involved in the sporulation process in *B. subtilis*, are known to be expressed as inactive precursors. Activation is achieved by regulated proteolytic processing of the N-terminus of these proteins ([@b39]; [@b44]; [@b63]). But in addition to its inhibitory function, the role of the extension of ECF41 proteins seems to be more complex. Partial deletion of the C-terminal extension results in high activity, but at least the N-terminal part of the extension is also required for transcription. Since a complete deletion of the C-terminal extension seems to decrease the affinity of the ECF41 σ factor to RNAP ([Fig. 5](#fig05){ref-type="fig"}), the N-terminal part of the extension could be involved in stabilizing the complex of RNAP and σ factor. So far, we do not know any inducing conditions for ECF41-dependent gene expression. Hence, we could not investigate the influence of the C-terminal extension in signal transduction under natural conditions. Expression of Ecf41~Bli~ is already sufficient to activate the target promoter, showing that the full-length protein is not completely unable to initiate transcription. But the resulting activity can be drastically increased by truncation of the ECF σ factor. Since these expression and promoter activity experiments were carried out heterologously in *B. subtilis*, which does not possess an ECF41 σ factor, it is unlikely that another protein is involved in the signal transduction.

Future studies will be necessary to unravel both the physiological role and the mechanistic details underlying ECF41-dependent signaling. But the data presented in this initial study clearly demonstrate the value of our ECF classification ([@b59]) and can serve as blueprint for studying additional conserved and novel groups of ECF σ factors, with yet to be explored mechanisms of signal transduction and gene regulation.
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